Concepedia

Barry S. Lutzke

BS

Statistics

Publications

14

Citations

693

H-Index

13

Active since

1991

Affiliations

W.E. Upjohn Institute for Employment Research(Current)

CNS Research (United States)

Eli Lilly (United States)

Barry S. Lutzke is an author at W.E. Upjohn Institute for Employment Research specializing in pharmacology, medicine, and life sciences.

Publications per year

1991–2024

14

Publications

14

Purification of an endogenous digitalislike factor from human plasma for structural analysis.

James H. Ludens, Michael Clark, Donald W. DuCharme et al. · Hypertension · 1991 · 155 citations

, , +17

(<i>S</i>)-(−)-4-[4-[2-(Isochroman-1-yl)ethyl]piperazin-1-yl]benzenesulfonamide, a Selective Dopamine D<sub>4</sub> Antagonist

Ruth E. TenBrink, Carol L. Bergh, J. Neil Duncan et al. · Journal of Medicinal Chemistry · 1996 · 98 citations · Full text

, , +9

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.

Kalpana Merchant, G.S. Gill, David W. Harris et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 89 citations · Full text

, , +15

Increased Lipophilicity and Subsequent Cell Partitioning Decrease Passive Transcellular Diffusion of Novel, Highly Lipophilic Antioxidants

Geri A. Sawada, Craig L. Barsuhn, Barry S. Lutzke et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 69 citations

, , +17

Pyrrolopyrimidines: Novel Brain-Penetrating Antioxidants with Neuroprotective Activity in Brain Injury and Ischemia Models

Edward D. Hall, Paula K. Andrus, Sarah L. Smith et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 64 citations

, , +14

1–5 of 14